SCIENTIFIC BACKGROUND

APC, ATM, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, CHEK2, DICER1, EPCAM, FH, FLCN, GREM1, MAX, MEN1, MET, MITF, MLH1, MLH3, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NTHL1, PALB2, PMS2, POLD1, POLE, POT1, PTCH1, PTEN, RAD51C, RAD51D, RET, RNF43, SDHA, SDHAF2, SDHB, SDHC, SDHD, SMAD4, STK11, SUFU, TMEM127, TP53, VHL

 

The comprehensive cancer panel analyses 54 genes associated with >30 cancer types spanning across 10 organs and systems including breast, ovary, colon, endocrine system, pancreas, stomach, prostate, skin, kidney and nervous system/brain. The outcome of the test can be a risk estimation of developing cancer from a genetic cause. If a person has an estimated high cancer risk, certain actions can be taken to reduce the likelihood of developing the cancer such as undergoing routine monitoring. Additionally, family members can be informed and encouraged to have a test.

 

If a pathogenic variant is identified in one of the associated genes, the risk of developing one of these syndromes is higher as compared to the average risk in the general population. Conversely, if a pathogenic variant is not identified, this does not preclude the possibility of developing cancer from unknown genetic factors or sporadic causes.

 

Our genetic counsellors can provide a detailed interpretation of the diagnostic report and advice on preventative measures and surveillance recommendations.

 
Disorders included
 

  • Basal Cell Carcinoma Syndrome/Gorlin-Goltz Syndrome
  • Birt-Hogg-Dub Syndrome
  • Breast Cancer
  • Colorectal Cancer
  • Constitutional Mismatch Repair Deficiency
  • DICER1 Syndrome
  • Familial Adenomatous Polyposis
  • Fanconi Anemia
  • Gastric Cancer
  • Hereditary Mixed Polyposis
  • Hyperparathyroidism-Jaw Tumor Syndrome
  • Juvenile Polyposis Syndrome
  • Leiomyomatosis and Renal Cell Cancer
  • Li-Fraumeni Syndrome
  • Lynch Syndrome
  • Medullary Thyroid Carcinoma
  • Melanoma
  • Multiple Endocrine Neoplasia (MEN) 1
  • MEN2
  • MEN4
  • Neurofibromatosis, Type I
  • Ovarian Cancer
  • Pancreatic Cancer
  • Paragangliomas
  • Parathyroid Carcinoma
  • Peutz-Jeghers Syndrome
  • Pheochromocytoma
  • PTEN Hamartoma Tumor Syndrome
  • Renal Cell Carcinoma
  • Sessile Serrated Polyposis Cancer Syndrome
  • Tumor Predisposition Syndrome
  • Von Hippel-Lindau Syndrome

 

 

Genes in bold are recommended by International guidelines, including German expert panels and/or have been more often associated with specific cancers.

GENES

APC, ATM, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, CHEK2, DICER1, EPCAM, FH, FLCN, GREM1, MAX, MEN1, MET, MITF, MLH1, MLH3, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NTHL1, PALB2, PMS2, POLD1, POLE, POT1, PTCH1, PTEN, RAD51C, RAD51D, RET, RNF43, SDHA, SDHAF2, SDHB, SDHC, SDHD, SMAD4, STK11, SUFU, TMEM127, TP53, VHL
How to order

LATEST ARTICLES

Traditional DNA tests may overlook 10% of classic in Familial Adenomatous Polyposis (FAP) cases. By integrating RNA sequencing, researchers unveiled ...

Read more

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more

In honor of the international day of women and girls in science, we interviewed one of our very own, Dr. Evelina Papaioannou. Dr. Evelina Pa...

Read more